Publications by authors named "D Knight"
Objectives: Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD.
Methods: In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions.
Background: Black cisgender women are disproportionately affected by HIV across the United States (US). Moreover, emerging adults continue to be significantly affected compared to women in older age groups. Yet in 2024, Black cisgender women and emerging adult women comprise a small fraction of HIV pre-exposure prophylaxis (PrEP) users in the US.
View Article and Find Full Text PDFComplete genome sequences of toxigenic isolated from Australian feral horses.
Microbiol Resour Announc
December 2024
Recent increases in community-associated infections have highlighted the importance of monitoring toxigenic from animal and environmental sources. We provide the complete circularized genomes of two toxigenic strains isolated from feral horse faeces. Genome N64 (sequence type 964) consists of a single chromosome of 4,078,791 bp, while genome H251 (sequence type 963) comprises one chromosome (4,304,722 bp) and three plasmids (150,942 bp, 11,534 bp, and 9,074 bp).
View Article and Find Full Text PDFArticle Synopsis
- Stigma and lack of social support create obstacles for HIV prevention among cisgender Black women, particularly in the U.S. South, leading to low rates of PrEP initiation and adherence.
- The study examined experiences with stigma and support among PrEP-naïve and experienced Black women in Mississippi through focus groups and interviews.
- Findings revealed themes of gendered racism, enacted and anticipated stigma regarding PrEP, strategies to cope with stigma, and the positive impact of social support on PrEP use and adherence.
Background: Many patients experience persistent symptoms after COVID-19, a syndrome referred to as Long COVID (LC). The goal of this study was to identify novel new or worsening comorbidities self-reported in patients with LC.
Methods: Patients diagnosed with LC ( = 732) at the Mayo Long COVID Care Clinic in Rochester, Minnesota and Jacksonville, Florida were sent questionnaires to assess the development of new or worsening comorbidities following COVID-19 compared to patients with SARS-CoV-2 that did not develop LC (controls).